For its third fiscal quarter (ending September 30), Vertex Pharmaceuticals Inc (NASDAQ: VRTX) has reported a 10% increase in E.P.S. from $3.63 a year ago to $4.01 in the current quarter. This performance was $0.03 […]
For its third fiscal quarter (ending September 30), Diamondback Energy Inc (NASDAQ: FANG) has reported a -25% decline in E.P.S. from $6.72 a year ago to $5.07 in the current quarter. Relative to the consensus […]
Coherent Corp (NYSE: COHR) has reported E.P.S. of $-0.65 for its first fiscal quarter (ending September 30) versus $-0.56 for the same period a year ago. Relative to the consensus estimate of $0.12, this was […]
Goodyear Tire & Rubber Co (NASDAQ: GT) has reported E.P.S. of $-0.31 for its third fiscal quarter (ending September 30) versus $0.16 for the same period a year ago — a decline of -294%. Relative […]
Graham Corp (NYSE: GHM) has reported earnings for its second fiscal quarter (ending September 30) of $0.04 versus a loss $-0.02 for the same period a year ago. For the latest four quarters through September […]
For its first fiscal quarter (ending September 30), Alpha and Omega Semiconductor Li (NASDAQ: AOSL) has reported a -78% decline in E.P.S. from $0.95 a year ago to $0.21 in the current quarter. This result […]
For its third fiscal quarter (ending September 30), CNO Financial Group Inc (NYSE: CNO) has reported a -4% decline in E.P.S. from $1.54 a year ago to $1.48 in the current quarter. Relative to the […]
CoreCivic Inc (NYSE: CXW) has reported E.P.S. of $0.12 for its third fiscal quarter (ending September 30) versus $0.59 for the same period a year ago — a decline of -80%. Relative to the consensus […]
For its fourth fiscal quarter (ending September 30), Cabot Corp (NYSE: CBT) has reported a 148% increase in E.P.S. from $1.65 a year ago to $4.10 in the current quarter. This performance was $2.62 better […]
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.75 for its third fiscal quarter (ending September 30) versus $-0.43 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research